Skip to main content

Table 2 Full schedule of assessments

From: Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)

 

Screening

Enrollment

Care visit(s)1

26 weeks

52 weeks

Administrative and behavioral procedures

 Informed consent

X

    

 Locator information

X

X

X

X

X

 MOUD counseling

X

X

X

X

X

 HIV risk reduction counseling and test results

X

X

X

X

X

 Offer condoms and lubricant

X

X

X

X

X

 Provide/facilitate access to harm reduction

X

X

X

X

X

 Demographic information

X

    

 Randomization

 

X

   

 Behavioral data collection

 

X

 

X

X

 Introduction to peer navigator

 

X

   

 Conclusion of peer navigation

   

X

 

Clinical evaluations/procedures

 Assessment for COVID-192

X

X

X

X

X

 Assessment for OUD3, recent injection drug use (track marks)4

X

X

   

 Targeted medical history to include MOUD treatment history, HIV risk behaviors, participation in other research studies5

X

X

(X)

X6

X6

 Basic physical exam7

 

X

(X)

  

 Screen for mental health needs and refer for services as indicated

 

X

(X)

X

X

 Initiate (intervention arm) or refer (active control arm) for HIV treatment or PrEP

 

(X8)

(X8)

  

 COWS assessment and initiate mobile unit-based MOUD treatment program (intervention arm only)

 

(X9)

(X9)

  

 Provide clinical management of MOUD and HIV infection or PrEP, including medication or prescription dispensation, as indicated

  

X

  

 HAV vaccination referral

  

X10

  

 HBV vaccination referral

  

X10

  

 HBV treatment/treatment referral

  

X10,11

  

 HCV treatment referral

  

X10

 

X

 Development of a clinical plan

 

X

   

 Empiric treatment of STIs (if symptomatic)

 

(X)

(X)

(X)

(X)

 Provide lab-based STI results and, if indicated, treatment (intervention arm) or referral (active control arm)

  

X12

  

 Provide lab-based STI results, and, if indicated, referral

   

X12

X12

 Provide clinical assessment and management or referral for other medical conditions

  

X

  

 Blood collection

X

X

(X)

X

X

 Urine collection

X

X

(X)

X

X

 Swabs for STI testing13

 

X

(X)

X

X

Laboratory evaluations/procedures

 HIV rapid testing

X

X14

(X)15

X15

X15

 Laboratory-based HIV testing (see SSP manual)

X16

X15

(X)15

X15

X15

 HIV viral load (people living with HIV only)

 

X

(X)

X

X

 CD4 cell count (people living with HIV only)

 

X

(X)

  

 MOUD testing (urine)17

X

X

 

X

X

 Substance use testing (urine)18

X

X

(X)

X

X

 Fentanyl testing (urine)

X

X

(X)

X

X

 Pregnancy testing (urine)19

 

X

(X)

(X)

(X)

 STI testing (syphilis, GC/CT NAAT)

 

X

(X)

X

X

 HCV Ab testing20

 

X

(X)

 

X

 HCV RNA (viral load)21

 

X

(X)

X

X

 HBV testing (HBsAg, HbsAb, HbcAb)

 

X

(X)

  

 Other HBV-related testing23

 

(X)

(X)

  

 HAV Ab testing

 

X

(X)

  

 Heme/Chem testing23

 

X

   

 Plasma storage24

X

X

 

X

X

 Urine storage25

 

X

 

X

X

 DBS storage (people without HIV only)26

 

X

 

X

X

 Serum storage for SARS-CoV-2 testing27

 

X

 

X

X

  1. Parentheses around an X indicate that this procedure will be done as needed
  2. See Supplemental material for the explanation of each superscript and additional testing for participants who test positive for HIV
  3. Abbreviations: Ab Antibody, ART Antiretroviral treatment, aPTT Activated partial thromboplastin time, COWS Clinical Opiate Withdrawal Scale, DBS Dried blood spot, GC/CT Gonorrhea/chlamydia, HAV Hepatitis A virus, HBV Hepatitis B virus, HBcAb HBV core antibody, HBsAb HBV surface antibody, HBsAg Hepatitis B surface antigen, HCV Hepatitis C virus, HLA Human leukocyte antigen, MOUD Medications for opioid use disorder, NAAT Nucleic acid amplification test, OUD Opioid use disorder, PT Prothrombin time, SDMC Statistical and Data Management Center, SSP Study-specific protocol, STI Sexually transmitted infection